Literature DB >> 18388117

Metformin-associated lactic acidosis in type 2 diabetes mellitus: incidence and presentation in common clinical practice.

Jaume Almirall, Meritxell Bricullé, José-Miguel Gonzalez-Clemente.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18388117     DOI: 10.1093/ndt/gfn152

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


× No keyword cloud information.
  15 in total

Review 1.  Drug therapy in patients with chronic renal failure.

Authors:  Bertram Hartmann; David Czock; Frieder Keller
Journal:  Dtsch Arztebl Int       Date:  2010-09-17       Impact factor: 5.594

2.  Retrospective analysis of lactic acidosis-related parameters upon and after metformin discontinuation in patients with diabetes and chronic kidney disease.

Authors:  Savas Sipahi; Yalcin Solak; Seyyid Bilal Acikgoz; Ahmed Bilal Genc; Mehmet Yildirim; Ulku Yilmaz; Ahmet Nalbant; Ali Tamer
Journal:  Int Urol Nephrol       Date:  2016-04-21       Impact factor: 2.370

3.  Toxicokinetics of metformin-associated lactic acidosis with continuous renal replacement therapy.

Authors:  Muhammad Mujtaba; Abdallah Sassine Geara; Machaiah Madhrira; Rajesh Agarwala; Herman Anderson; Jen-Tse Cheng; Sumit Mohan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-08-29       Impact factor: 2.441

4.  The Role of Metformin in Metformin-Associated Lactic Acidosis (MALA): Case Series and Formulation of a Model of Pathogenesis.

Authors:  Janna K Duong; Timothy J Furlong; Darren M Roberts; Garry G Graham; Jerry R Greenfield; Kenneth M Williams; Richard O Day
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

5.  The Association between Metformin Therapy and Lactic Acidosis.

Authors:  Isabelle H S Kuan; Ruth L Savage; Stephen B Duffull; Robert J Walker; Daniel F B Wright
Journal:  Drug Saf       Date:  2019-12       Impact factor: 5.606

6.  Impact of acute kidney injury on metformin-associated lactic acidosis.

Authors:  Yao-Ko Wen
Journal:  Int Urol Nephrol       Date:  2009-03-12       Impact factor: 2.370

Review 7.  Metformin associated lactic acidosis (MALA): clinical profiling and management.

Authors:  Alessandra Moioli; Barbara Maresca; Andrea Manzione; Antonello Maria Napoletano; Daniela Coclite; Nicola Pirozzi; Giorgio Punzo; Paolo Menè
Journal:  J Nephrol       Date:  2016-01-22       Impact factor: 3.902

Review 8.  Achieving glycemic control in elderly patients with type 2 diabetes: a critical comparison of current options.

Authors:  Ye-Fong Du; Horng-Yih Ou; Elizabeth A Beverly; Ching-Ju Chiu
Journal:  Clin Interv Aging       Date:  2014-11-18       Impact factor: 4.458

9.  Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42).

Authors:  Kazuya Fujihara; Risa Igarashi; Satoshi Matsunaga; Yasuhiro Matsubayashi; Takaho Yamada; Hiroki Yokoyama; Shiro Tanaka; Hitoshi Shimano; Hiroshi Maegawa; Katsuya Yamazaki; Koichi Kawai; Hirohito Sone
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

10.  Comparison of clinical characteristics in patients with type 2 diabetes among whom different antihyperglycemic agents were prescribed as monotherapy or combination therapy by diabetes specialists.

Authors:  Kazuya Fujihara; Osamu Hanyu; Yoriko Heianza; Akiko Suzuki; Takaho Yamada; Hiroki Yokoyama; Shiro Tanaka; Hiroaki Yagyu; Hitoshi Shimano; Atsunori Kashiwagi; Katuya Yamazaki; Koichi Kawai; Hirohito Sone
Journal:  J Diabetes Investig       Date:  2015-07-26       Impact factor: 4.232

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.